Release of iron from ferritin requires lysosomal activity

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 3, 2006, Pages

  Kidane, Theodros Z ^a   Sauble, Eric ^a   Linder, Maria C ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Degradation; Proteasomes

Indexed keywords

CHLOROQUINE; CHYMOSTATIN; DEFEROXAMINE; FERRITIN; IRON; LEUPEPTIN;

ARTICLE; AUTORADIOGRAPHY; CELL TYPE; FRACTIONATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOELECTROPHORESIS; LEUKEMIA CELL; LYSOSOME; PRIORITY JOURNAL;

ANIMALS; CACO-2 CELLS; CHLOROQUINE; DEFEROXAMINE; ENTEROCYTES; ERYTHROID CELLS; FERRITINS; HEPATOCYTES; HUMANS; IMMUNOELECTROPHORESIS; IRON; K562 CELLS; LEUPEPTINS; LYSOSOMES; OLIGOPEPTIDES; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; RATS;

EID: 33748417446     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00505.2005     Document Type: Article

References (49)

1. Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol 36: 2137-2143, 2004.
2. Andrews SC, Arosio P, Bottke W, Briat JF, von Darl M, Harrison PM, Laulhere JP, Levi S, Lobreaux S, and Yewdall SJ. Structure, function, and evolution of ferritins. J Inorg Biochem 47: 161-174, 1992.
3. Billington D, Maltby PJ, Jackson AP, and Graham JM. Dissection of hepatic receptor-mediated endocytic pathways using self-generated gradients of iodixanol (Optiprep). Anal Biochem 258: 251-258, 1998.
4. Bridges KR. Ascorbic acid inhibits lysosomal autophagy of ferritin. J Biol Chem 262: 14773-14778, 1987.
5. Chasteen ND and Harrison PM. Mineralization of ferritin: an efficient means of iron storage. J Struct Biol 126: 182-194, 1999.
6. D'Estaintot BL, Santambrogio P, Granier T, Gallois B, Chevalier JM, Precigoux G, Levi S, and Arosio P. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. J Mol Biol 340: 277-293, 2004.
7. Endo T, Ishibashi Y, Okana H, and Fukumaki Y. Significance of pH on differentiation of human erythroid cell lines. Leuk Res 18: 49-54, 1994.
8. Faa G, Terlizzo M, Gerosa C, Congui T, and Angelucci E. Patterns of iron distribution in liver cells in β-thalassemia studied by x-ray microanalysis. Haematologica 87: 479-484, 2002.
9. Ford GC, Harrison PM, Rice DW, Smith JMA, Treffry A, White JL, and Yariv J. Ferritin: design and formation of an iron-storage molecule. Philos Trans R Soc Lond B Biol Sci 304: 551-565, 1984.
10. Ford T, Graham J, and Rickwood D. Iodixanol: a non-ionic iso-osmotic centrifugation medium for the formation of self-generated gradients. Anal Biochem 220: 360-366, 1994.
11. Garner B, Roberg K, and Brunk UT. Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress. Free Radic Res 29: 103-114, 1998.
12. Graham J, Ford T, and Rickwood D. The preparation of subcellular organelles from mouse liver in self-generated gradients of iodixanol. Anal Biochem 220: 367-373, 1994.
13. Hernandez-Yago J, Knecht E, Martinez-Ramon A, and Grisola S. Autophagy of ferritin incorporated into the cytosol of HeLa cells by liposomes. Cell Tissue Res 205: 303-309, 1980.
14. Hoffman KE, Yanelli K, and Bridges KR. Ascorbic acid and iron metabolism: alterations in lysosomal function. Am J Clin Nutr 54: 1188S-1192S, 1991.
15. Hultkranz R and Glauman H. Intracellular fate of ferritin in HeLa cells following microinjection. Exp Cell Res 171: 203-212, 1987.
16. Iacopetta BJ, Morgan EH, and Yeoh GC. Receptor-medited endocytosis of transferrin by developing erythroid cells from the fetal rat liver. J Histochem Cytochem 31: 336-344, 1983.
17. Jeffers M, Taylor GA, Weidner KM, Omura S, and Vande Woude GF. Degradation of the Met tyrosine kinase receptor by ubiquitin-proteasome pathway. Mol Cell Biol 17: 799-808, 1997.
18. Konijn AM, Glickstein H, Vaisman B, Meyron-Holtz EG, Slotki IN, and Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 94: 2128-2134. 1999.
19. Kwok JC and Richardson DR. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway. Mol Pharmacol 63: 849-861, 2003.
20. Kwok JC and Richardson DR. Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol Pharmacol 665: 181-195, 2004.
21. Linder MC, Kakavandi H, Miller P, and Nagel GN. Dissociation of ferritins. Arch Biochem Biophys 269: 485-496, 1989.
22. Linder MC (Editor). Nutrition and metabolism of trace elements. In: Nutritional Biochemistry and Metabolism (2nd ed.). New York: Elsevier/Appleton-Lange, 1991, p. 215-226.
23. Linder MC and Munro HN. Assay of tissue ferritin. Anal Biochem 48: 266-278, 1972.
24. Linder-Horowitz MC, Ruettinger RT, and Munro HN. Iron induction of electrophoretically-different ferritins in rat liver, heart, and kidney. Biochim Biophys Acta 200: 442-448, 1970.
25. Liu X and Theil EC. Ferritin reactions: direct identification of the site for the diferric peroxide reaction intermediate. Acc Chem Res 38: 167-175, 2005.
26. Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, and Stitt AW. Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 28: 277-284, 2004.
27. Mehlhase J, Sandig G, Pantopoulos K, and Grune T. Oxidationinduced ferritin turnover in microglial cells: role of proteasome. Free Radic Biol Med 38: 276-285, 2005.
28. Munro HN and Linder MC. Ferritin: structure, biosynthesis, and role in iron metabolism. Physiol Rev 58: 317-396, 1978.
29. Neff NT, Demartino GN, and Goldberg AL. The effect of protease inhibitors and decreased temperature on the degradation of different classes of proteins in cultured hepatocytes. J Cell Physiol 101: 439-457, 1979.
30. Ollinger K and Roberg K. Nutrient deprivation of cultured rat hepatocytes increases the desferrioxamine-available iron pool and augments the sensitivity of hydrogen peroxide. J Biol Chem 272: 23707-23711, 1997.
31. Persson HL, Nilsson KJ, and Brunk UT. Novel cellular defenses against iron and oxidation: ferritin and autophagocytosis preserve lysosomal stability in airway epithelium. Redox Rep 6: 57-63, 2001.
32. Pourzand C, Watkin RD, Brown JE, and Tyrrell RM. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc Natl Acad Sci USA 96: 6751-6756, 1999.
33. Radisky DC and Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem J 336: 201-205, 1988.
34. Roberts S and Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem 263: 19181-19187, 1988.
35. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, and Goldberg AL. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771, 1994.
36. Rudeck M, Volk T, Sitte N, and Grune T. Ferritin oxidation in vitro: implication of iron release and degradation by the 20S proteasome. IUBMB Life 49: 451-456, 2000.
37. Scheiber-Mojdehkar B, Zimmermann I, Dresow B, and Goldenberg H. Differential response of non-transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol 31: 61-70, 1999.
38. Shringarpure R, Grune T, Mehlhase J, and Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 278: 311-318, 2003.
39. Storrie B and Madden EA. Isolation of subcellular organelles. In: Guide to Protein Purification, edited by Deutschler MP. San Diego, CA: Academic, 1990, p. 215-216.
40. Theil EC. Ferritin. In: Handbook of Metalloproteins, edited by Messerschmidt A, Huber R, Weighardt K, and Poulos T. Chichester, UK: Wiley, 2001, p. 771-781.
41. Theil EC. Iron, ferritin, and nutrition. Annu Rev Nutr 24: 327-343, 2004.
42. Theil EC and Eisenstein RS. Combinatorial mRNA regulation: iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). J Biol Chem 275: 40659-40662, 2002.
43. Treffry A, Gelvan D, Konijn AM, and Harrison PM. Ferritin does not accumulate iron oxidized by ceruloplasmin. Biochem J 305: 21-23, 1995.
44. Trinder D and Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 35: 292-296, 2003.
45. Truty J, Malpe R, and Linder MC. Iron prevents ferritin turnover in hepatic cells. J Biol Chem 276: 48775-48780, 2001.
46. Vaisman B, Fibach E, and Konijn AM. Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors. Blood 90: 831-838, 1997.
47. Vidal R, Ghetti B, Takao M, Brefel-Courbon C, Uro-Coste E, Glazier BS, Siani V, Benson MD, Calvas P, Miravalle L, Rascol O, and Delisle MB. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 63: 363-388, 2004.
48. Witt O, Schmejkal S, and Pekrun A. Tributyrin plus all-trans retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemic cells. Am J Hematol 64: 319-321, 2000.
49. Zerounian NR and Linder MC. Effects of copper and ceruloplasmin on iron transport in the Caco2 cell intestinal model. J Nutr Biochem 13: 138-148, 2002.